

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein heterotrimerization (GO:0070208) | 6.40772124 |
| 2 | cell migration involved in heart development (GO:0060973) | 4.71905462 |
| 3 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 4.46167384 |
| 4 | barbed-end actin filament capping (GO:0051016) | 4.42483474 |
| 5 | extracellular fibril organization (GO:0043206) | 4.36314091 |
| 6 | muscle filament sliding (GO:0030049) | 4.31982394 |
| 7 | actin-myosin filament sliding (GO:0033275) | 4.31982394 |
| 8 | keratan sulfate catabolic process (GO:0042340) | 4.30405221 |
| 9 | collagen fibril organization (GO:0030199) | 4.29459063 |
| 10 | negative regulation of heart growth (GO:0061117) | 4.27024056 |
| 11 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 4.27024056 |
| 12 | regulation of skeletal muscle contraction (GO:0014819) | 4.25989384 |
| 13 | plasma membrane repair (GO:0001778) | 4.23757389 |
| 14 | regulation of sequestering of triglyceride (GO:0010889) | 4.20779210 |
| 15 | sarcomere organization (GO:0045214) | 4.19889712 |
| 16 | cardiac myofibril assembly (GO:0055003) | 4.16830873 |
| 17 | extracellular matrix assembly (GO:0085029) | 4.12273850 |
| 18 | skeletal muscle adaptation (GO:0043501) | 4.11458202 |
| 19 | carnitine shuttle (GO:0006853) | 4.06818959 |
| 20 | fatty acid transmembrane transport (GO:1902001) | 3.93841665 |
| 21 | myofibril assembly (GO:0030239) | 3.86768648 |
| 22 | endothelium development (GO:0003158) | 3.78584047 |
| 23 | collagen metabolic process (GO:0032963) | 3.76284830 |
| 24 | low-density lipoprotein particle clearance (GO:0034383) | 3.72814586 |
| 25 | virion attachment to host cell (GO:0019062) | 3.71440405 |
| 26 | adhesion of symbiont to host cell (GO:0044650) | 3.71440405 |
| 27 | transcytosis (GO:0045056) | 3.70703318 |
| 28 | fibril organization (GO:0097435) | 3.69855150 |
| 29 | multicellular organismal macromolecule metabolic process (GO:0044259) | 3.68559061 |
| 30 | ovulation from ovarian follicle (GO:0001542) | 3.67490165 |
| 31 | positive regulation of fatty acid oxidation (GO:0046321) | 3.63707591 |
| 32 | actin-mediated cell contraction (GO:0070252) | 3.63026377 |
| 33 | collagen catabolic process (GO:0030574) | 3.58381561 |
| 34 | lipid particle organization (GO:0034389) | 3.57106994 |
| 35 | positive regulation of receptor recycling (GO:0001921) | 3.54589072 |
| 36 | multicellular organismal metabolic process (GO:0044236) | 3.52849503 |
| 37 | regulation of p38MAPK cascade (GO:1900744) | 3.51858674 |
| 38 | multicellular organismal catabolic process (GO:0044243) | 3.38640343 |
| 39 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.35412528 |
| 40 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.34523209 |
| 41 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.33705147 |
| 42 | regulation of fatty acid oxidation (GO:0046320) | 3.32510059 |
| 43 | blood vessel maturation (GO:0001955) | 3.28815366 |
| 44 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.25698544 |
| 45 | negative regulation of smooth muscle cell migration (GO:0014912) | 3.25416176 |
| 46 | adhesion of symbiont to host (GO:0044406) | 3.24873363 |
| 47 | bone trabecula formation (GO:0060346) | 3.20225247 |
| 48 | brown fat cell differentiation (GO:0050873) | 3.18880102 |
| 49 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.18213619 |
| 50 | endocrine hormone secretion (GO:0060986) | 3.17794186 |
| 51 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.16913862 |
| 52 | epithelial cell-cell adhesion (GO:0090136) | 3.15692278 |
| 53 | myelination in peripheral nervous system (GO:0022011) | 3.15315048 |
| 54 | peripheral nervous system axon ensheathment (GO:0032292) | 3.15315048 |
| 55 | heart trabecula formation (GO:0060347) | 3.13958869 |
| 56 | carnitine transmembrane transport (GO:1902603) | 3.13408989 |
| 57 | hemidesmosome assembly (GO:0031581) | 3.10989228 |
| 58 | negative regulation of muscle hypertrophy (GO:0014741) | 3.10918208 |
| 59 | glomerular filtration (GO:0003094) | 3.10789647 |
| 60 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 3.10407596 |
| 61 | response to dietary excess (GO:0002021) | 3.08735978 |
| 62 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.08581881 |
| 63 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.08581881 |
| 64 | negative regulation of granulocyte differentiation (GO:0030853) | 3.07741637 |
| 65 | positive regulation of vasculogenesis (GO:2001214) | 3.06910637 |
| 66 | positive regulation of p38MAPK cascade (GO:1900745) | 3.05862509 |
| 67 | ethanol oxidation (GO:0006069) | 3.03936749 |
| 68 | skin morphogenesis (GO:0043589) | 3.03798247 |
| 69 | white fat cell differentiation (GO:0050872) | 3.03241497 |
| 70 | extracellular matrix disassembly (GO:0022617) | 3.02702040 |
| 71 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.02661356 |
| 72 | growth hormone secretion (GO:0030252) | 3.02089897 |
| 73 | tricarboxylic acid cycle (GO:0006099) | 3.01793407 |
| 74 | negative regulation of stress fiber assembly (GO:0051497) | 3.01143066 |
| 75 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.99701158 |
| 76 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.99646590 |
| 77 | negative regulation of platelet activation (GO:0010544) | 2.98961525 |
| 78 | trabecula formation (GO:0060343) | 2.98703197 |
| 79 | creatine metabolic process (GO:0006600) | 2.98647743 |
| 80 | basement membrane organization (GO:0071711) | 2.97172737 |
| 81 | actomyosin structure organization (GO:0031032) | 2.97164913 |
| 82 | glomerular basement membrane development (GO:0032836) | 2.96427070 |
| 83 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.96241309 |
| 84 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.95497725 |
| 85 | negative regulation of cartilage development (GO:0061037) | 2.95314925 |
| 86 | type B pancreatic cell proliferation (GO:0044342) | 2.93084147 |
| 87 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.92863427 |
| 88 | oxygen transport (GO:0015671) | 2.91849266 |
| 89 | NADH metabolic process (GO:0006734) | 2.91567234 |
| 90 | triglyceride catabolic process (GO:0019433) | 2.91368245 |
| 91 | renal filtration (GO:0097205) | 2.90574567 |
| 92 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.90372804 |
| 93 | actin filament-based movement (GO:0030048) | 2.89553033 |
| 94 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.89245093 |
| 95 | protein localization to cell surface (GO:0034394) | 2.88831960 |
| 96 | cardiac muscle cell development (GO:0055013) | 2.87452328 |
| 97 | endothelial cell morphogenesis (GO:0001886) | 2.87346279 |
| 98 | cardiac muscle contraction (GO:0060048) | 2.86609452 |
| 99 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 2.86204129 |
| 100 | valine metabolic process (GO:0006573) | 2.85513168 |
| 101 | striated muscle hypertrophy (GO:0014897) | 2.84839480 |
| 102 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.83987819 |
| 103 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.83266636 |
| 104 | carnitine transport (GO:0015879) | 2.82665558 |
| 105 | amino-acid betaine transport (GO:0015838) | 2.82665558 |
| 106 | apoptotic cell clearance (GO:0043277) | 2.82464963 |
| 107 | desmosome organization (GO:0002934) | 2.79569130 |
| 108 | angiogenesis involved in wound healing (GO:0060055) | 2.79005036 |
| 109 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.77606640 |
| 110 | venous blood vessel morphogenesis (GO:0048845) | 2.77449738 |
| 111 | glycerolipid catabolic process (GO:0046503) | 2.77113273 |
| 112 | regulation of cholesterol storage (GO:0010885) | 2.76942295 |
| 113 | biotin metabolic process (GO:0006768) | 2.74913668 |
| 114 | cardiac cell development (GO:0055006) | 2.74715649 |
| 115 | protein trimerization (GO:0070206) | 2.73865371 |
| 116 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.73312994 |
| 117 | cellular response to epinephrine stimulus (GO:0071872) | 2.72879492 |
| 118 | cGMP-mediated signaling (GO:0019934) | 2.72723410 |
| 119 | polyol transport (GO:0015791) | 2.72490375 |
| 120 | positive regulation of macrophage cytokine production (GO:0060907) | 2.70829393 |
| 121 | cellular response to vitamin (GO:0071295) | 2.70750565 |
| 122 | endodermal cell differentiation (GO:0035987) | 2.70450661 |
| 123 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.69183275 |
| 124 | complement activation, classical pathway (GO:0006958) | 2.67243172 |
| 125 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.66993824 |
| 126 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.66186586 |
| 127 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.65285164 |
| 128 | complement activation, alternative pathway (GO:0006957) | 2.64728626 |
| 129 | complement activation (GO:0006956) | 2.63779276 |
| 130 | metanephric mesenchyme development (GO:0072075) | 2.63705801 |
| 131 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.63677613 |
| 132 | negative regulation of vascular permeability (GO:0043116) | 2.61459866 |
| 133 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.59949978 |
| 134 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.59628914 |
| 135 | lipid storage (GO:0019915) | 2.59337864 |
| 136 | peptide cross-linking (GO:0018149) | 2.58819732 |
| 137 | positive regulation of cholesterol efflux (GO:0010875) | 2.58523586 |
| 138 | regulation of cardiac muscle cell differentiation (GO:2000725) | 2.58449926 |
| 139 | stress fiber assembly (GO:0043149) | 2.58415865 |
| 140 | glycosaminoglycan catabolic process (GO:0006027) | 2.57979746 |
| 141 | muscle hypertrophy (GO:0014896) | 2.57011368 |
| 142 | acylglycerol catabolic process (GO:0046464) | 2.56998199 |
| 143 | neutral lipid catabolic process (GO:0046461) | 2.56998199 |
| 144 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.56133608 |
| 145 | striated muscle adaptation (GO:0014888) | 2.55615809 |
| 146 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.55224598 |
| 147 | cell-substrate junction assembly (GO:0007044) | 2.55030541 |
| 148 | negative regulation of cardiac muscle tissue development (GO:0055026) | 2.55028376 |
| 149 | fatty acid beta-oxidation (GO:0006635) | 2.54083472 |
| 150 | fatty acid homeostasis (GO:0055089) | 2.53566747 |
| 151 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.51754390 |
| 152 | sulfur compound catabolic process (GO:0044273) | 2.50362529 |
| 153 | negative regulation of protein autophosphorylation (GO:0031953) | 2.49990782 |
| 154 | positive regulation of fat cell differentiation (GO:0045600) | 2.49374466 |
| 155 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.48762568 |
| 156 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.46910190 |
| 157 | keratan sulfate biosynthetic process (GO:0018146) | 2.46550256 |
| 158 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.46011424 |
| 159 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.45310465 |
| 160 | phagocytosis, recognition (GO:0006910) | 2.45082816 |
| 161 | regulation of macrophage chemotaxis (GO:0010758) | 2.43428884 |
| 162 | cAMP biosynthetic process (GO:0006171) | 2.42588931 |
| 163 | dermatan sulfate metabolic process (GO:0030205) | 2.38235674 |
| 164 | kidney mesenchyme development (GO:0072074) | 2.37445526 |
| 165 | ethanol metabolic process (GO:0006067) | 2.36540216 |
| 166 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.36524370 |
| 167 | cell proliferation involved in metanephros development (GO:0072203) | 2.35488139 |
| 168 | dermatan sulfate biosynthetic process (GO:0030208) | 2.34966675 |
| 169 | regulation of vasculogenesis (GO:2001212) | 2.34922229 |
| 170 | positive regulation of glucose import (GO:0046326) | 2.34382131 |
| 171 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.34043774 |
| 172 | UV protection (GO:0009650) | 2.33533338 |
| 173 | glial cell migration (GO:0008347) | 2.31756654 |
| 174 | chondroitin sulfate catabolic process (GO:0030207) | 2.31031712 |
| 175 | aminoglycan catabolic process (GO:0006026) | 2.30649662 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.49971612 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.02504328 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.00653429 |
| 4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.51687523 |
| 5 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.40925411 |
| 6 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.96137059 |
| 7 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.55709477 |
| 8 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.52898265 |
| 9 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.23108564 |
| 10 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.17566948 |
| 11 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.15243369 |
| 12 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.05687342 |
| 13 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.05687342 |
| 14 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.97600778 |
| 15 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.96150250 |
| 16 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.95206642 |
| 17 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.72321870 |
| 18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.71866720 |
| 19 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.70293186 |
| 20 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.67475991 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.66064138 |
| 22 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.65933513 |
| 23 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.64744630 |
| 24 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.64522281 |
| 25 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.64108039 |
| 26 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.63287986 |
| 27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.59352988 |
| 28 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.57826711 |
| 29 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.53105950 |
| 30 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.49193033 |
| 31 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.43448268 |
| 32 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.41501120 |
| 33 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.40814512 |
| 34 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.40417728 |
| 35 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.40218447 |
| 36 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.40144566 |
| 37 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.39668477 |
| 38 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.39608920 |
| 39 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.39006259 |
| 40 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.39006259 |
| 41 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.35369947 |
| 42 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.35311064 |
| 43 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.34978396 |
| 44 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.32374060 |
| 45 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.31124731 |
| 46 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.30173926 |
| 47 | GATA1_22025678_ChIP-Seq_K562_Human | 1.29514742 |
| 48 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.29137235 |
| 49 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.27991972 |
| 50 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.27365694 |
| 51 | KDM2B_26808549_Chip-Seq_K562_Human | 1.26470906 |
| 52 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.24979690 |
| 53 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.22929466 |
| 54 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.22560095 |
| 55 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.21708169 |
| 56 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.21599045 |
| 57 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.21070665 |
| 58 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.19432927 |
| 59 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.19390522 |
| 60 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.19172476 |
| 61 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18303022 |
| 62 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.16572781 |
| 63 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.16412210 |
| 64 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.15189320 |
| 65 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.13799678 |
| 66 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.11054579 |
| 67 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.11043884 |
| 68 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.10625486 |
| 69 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.08608084 |
| 70 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.08039073 |
| 71 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07776398 |
| 72 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.07432826 |
| 73 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.07185635 |
| 74 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.06112568 |
| 75 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.03555459 |
| 76 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.02628845 |
| 77 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.02203594 |
| 78 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.01413261 |
| 79 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.00272759 |
| 80 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.00068090 |
| 81 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.99975536 |
| 82 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.99808245 |
| 83 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98821344 |
| 84 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98676395 |
| 85 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.98176109 |
| 86 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.97936344 |
| 87 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.97173555 |
| 88 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.97119171 |
| 89 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.96853409 |
| 90 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.96835760 |
| 91 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.96630110 |
| 92 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.96559428 |
| 93 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.95310147 |
| 94 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95112384 |
| 95 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.94971857 |
| 96 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.94116202 |
| 97 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.93917504 |
| 98 | ATF3_27146783_Chip-Seq_COLON_Human | 0.93833512 |
| 99 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.93657429 |
| 100 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.93639183 |
| 101 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.93467002 |
| 102 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.92899882 |
| 103 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.92317623 |
| 104 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.90141319 |
| 105 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.89323113 |
| 106 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.89208505 |
| 107 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.89186017 |
| 108 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.88778328 |
| 109 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.87816190 |
| 110 | SA1_27219007_Chip-Seq_Bcells_Human | 0.87720773 |
| 111 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.87438889 |
| 112 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.87200153 |
| 113 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86614572 |
| 114 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.86213500 |
| 115 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.85956573 |
| 116 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.85949427 |
| 117 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.85730183 |
| 118 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.85689134 |
| 119 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.85573029 |
| 120 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.85573029 |
| 121 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.83873432 |
| 122 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.82739833 |
| 123 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.82550265 |
| 124 | * CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.81832112 |
| 125 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.81039558 |
| 126 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.80332406 |
| 127 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.78491706 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 6.92745285 |
| 2 | MP0005275_abnormal_skin_tensile | 6.18118994 |
| 3 | MP0005503_abnormal_tendon_morphology | 4.25213215 |
| 4 | MP0000751_myopathy | 4.12279055 |
| 5 | MP0002837_dystrophic_cardiac_calcinosis | 4.00590934 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 3.07242840 |
| 7 | MP0001958_emphysema | 2.96550729 |
| 8 | MP0004130_abnormal_muscle_cell | 2.59443251 |
| 9 | MP0004084_abnormal_cardiac_muscle | 2.52033017 |
| 10 | MP0003646_muscle_fatigue | 2.47488496 |
| 11 | MP0005670_abnormal_white_adipose | 2.47164244 |
| 12 | MP0004272_abnormal_basement_membrane | 2.35576035 |
| 13 | MP0000749_muscle_degeneration | 2.26212023 |
| 14 | MP0000750_abnormal_muscle_regeneration | 2.25779806 |
| 15 | MP0005666_abnormal_adipose_tissue | 2.21818875 |
| 16 | MP0004185_abnormal_adipocyte_glucose | 2.21760791 |
| 17 | MP0004036_abnormal_muscle_relaxation | 2.21238291 |
| 18 | MP0005330_cardiomyopathy | 2.07053775 |
| 19 | MP0002108_abnormal_muscle_morphology | 2.05008148 |
| 20 | MP0002060_abnormal_skin_morphology | 2.00724715 |
| 21 | MP0003279_aneurysm | 1.92771404 |
| 22 | MP0004087_abnormal_muscle_fiber | 1.91871921 |
| 23 | MP0005257_abnormal_intraocular_pressure | 1.81890453 |
| 24 | MP0004215_abnormal_myocardial_fiber | 1.78671614 |
| 25 | MP0005375_adipose_tissue_phenotype | 1.76469858 |
| 26 | MP0005620_abnormal_muscle_contractility | 1.69369955 |
| 27 | MP0002106_abnormal_muscle_physiology | 1.66689391 |
| 28 | MP0001542_abnormal_bone_strength | 1.66115990 |
| 29 | MP0000013_abnormal_adipose_tissue | 1.63462637 |
| 30 | MP0005369_muscle_phenotype | 1.61244887 |
| 31 | MP0005385_cardiovascular_system_phenoty | 1.57603068 |
| 32 | MP0001544_abnormal_cardiovascular_syste | 1.57603068 |
| 33 | MP0003566_abnormal_cell_adhesion | 1.55793752 |
| 34 | MP0006138_congestive_heart_failure | 1.54963702 |
| 35 | MP0000759_abnormal_skeletal_muscle | 1.54957227 |
| 36 | MP0004145_abnormal_muscle_electrophysio | 1.52913366 |
| 37 | MP0010368_abnormal_lymphatic_system | 1.52458630 |
| 38 | MP0002972_abnormal_cardiac_muscle | 1.48703663 |
| 39 | MP0006054_spinal_hemorrhage | 1.47740847 |
| 40 | MP0003329_amyloid_beta_deposits | 1.43328858 |
| 41 | MP0008775_abnormal_heart_ventricle | 1.39653921 |
| 42 | MP0000747_muscle_weakness | 1.37565202 |
| 43 | MP0003011_delayed_dark_adaptation | 1.29690076 |
| 44 | MP0000003_abnormal_adipose_tissue | 1.28865524 |
| 45 | MP0003828_pulmonary_edema | 1.28170017 |
| 46 | MP0010630_abnormal_cardiac_muscle | 1.27958740 |
| 47 | MP0001879_abnormal_lymphatic_vessel | 1.26887605 |
| 48 | MP0000343_altered_response_to | 1.25867146 |
| 49 | MP0002796_impaired_skin_barrier | 1.25345833 |
| 50 | MP0005508_abnormal_skeleton_morphology | 1.24122978 |
| 51 | MP0004484_altered_response_of | 1.18259714 |
| 52 | MP0005164_abnormal_response_to | 1.17012655 |
| 53 | MP0002269_muscular_atrophy | 1.14190831 |
| 54 | MP0002295_abnormal_pulmonary_circulatio | 1.13345440 |
| 55 | MP0002971_abnormal_brown_adipose | 1.12402856 |
| 56 | MP0001533_abnormal_skeleton_physiology | 1.07353300 |
| 57 | MP0000604_amyloidosis | 1.05952989 |
| 58 | MP0003950_abnormal_plasma_membrane | 1.04232597 |
| 59 | MP0002876_abnormal_thyroid_physiology | 1.04038912 |
| 60 | MP0010329_abnormal_lipoprotein_level | 1.03519249 |
| 61 | MP0003186_abnormal_redox_activity | 1.03353555 |
| 62 | MP0000733_abnormal_muscle_development | 1.02416524 |
| 63 | MP0001243_abnormal_dermal_layer | 1.01977320 |
| 64 | MP0004883_abnormal_blood_vessel | 0.97269604 |
| 65 | MP0005058_abnormal_lysosome_morphology | 0.96705597 |
| 66 | MP0005623_abnormal_meninges_morphology | 0.96060018 |
| 67 | MP0010030_abnormal_orbit_morphology | 0.95308263 |
| 68 | MP0003959_abnormal_lean_body | 0.94846963 |
| 69 | MP0000579_abnormal_nail_morphology | 0.93560072 |
| 70 | MP0005535_abnormal_body_temperature | 0.93281131 |
| 71 | MP0003690_abnormal_glial_cell | 0.90941007 |
| 72 | MP0002166_altered_tumor_susceptibility | 0.90302022 |
| 73 | MP0003091_abnormal_cell_migration | 0.87707557 |
| 74 | MP0004858_abnormal_nervous_system | 0.87003191 |
| 75 | MP0003137_abnormal_impulse_conducting | 0.85587020 |
| 76 | MP0009115_abnormal_fat_cell | 0.85082546 |
| 77 | MP0000767_abnormal_smooth_muscle | 0.82624025 |
| 78 | MP0003191_abnormal_cellular_cholesterol | 0.80108897 |
| 79 | MP0002234_abnormal_pharynx_morphology | 0.79524485 |
| 80 | * MP0000163_abnormal_cartilage_morphology | 0.79424333 |
| 81 | MP0002133_abnormal_respiratory_system | 0.78805432 |
| 82 | MP0005388_respiratory_system_phenotype | 0.78805432 |
| 83 | MP0003724_increased_susceptibility_to | 0.78541875 |
| 84 | MP0003075_altered_response_to | 0.77752238 |
| 85 | MP0003045_fibrosis | 0.77447467 |
| 86 | MP0004085_abnormal_heartbeat | 0.77076964 |
| 87 | MP0002896_abnormal_bone_mineralization | 0.76923147 |
| 88 | MP0005023_abnormal_wound_healing | 0.75888256 |
| 89 | MP0010386_abnormal_urinary_bladder | 0.75368290 |
| 90 | MP0005367_renal/urinary_system_phenotyp | 0.75155317 |
| 91 | MP0000516_abnormal_urinary_system | 0.75155317 |
| 92 | MP0005165_increased_susceptibility_to | 0.74119151 |
| 93 | MP0002127_abnormal_cardiovascular_syste | 0.73937071 |
| 94 | MP0005595_abnormal_vascular_smooth | 0.72305381 |
| 95 | MP0002006_tumorigenesis | 0.72041521 |
| 96 | MP0000534_abnormal_ureter_morphology | 0.71822945 |
| 97 | MP0005334_abnormal_fat_pad | 0.71460012 |
| 98 | MP0002128_abnormal_blood_circulation | 0.70829341 |
| 99 | MP0009780_abnormal_chondrocyte_physiolo | 0.69802596 |
| 100 | MP0003221_abnormal_cardiomyocyte_apopto | 0.69474635 |
| 101 | MP0002933_joint_inflammation | 0.69259587 |
| 102 | MP0001614_abnormal_blood_vessel | 0.68195571 |
| 103 | MP0010771_integument_phenotype | 0.68137666 |
| 104 | MP0002118_abnormal_lipid_homeostasis | 0.67975490 |
| 105 | MP0005390_skeleton_phenotype | 0.67638712 |
| 106 | MP0000266_abnormal_heart_morphology | 0.67449040 |
| 107 | MP0002115_abnormal_skeleton_extremities | 0.66894913 |
| 108 | MP0004510_myositis | 0.66893175 |
| 109 | MP0009840_abnormal_foam_cell | 0.65296429 |
| 110 | MP0004233_abnormal_muscle_weight | 0.65016294 |
| 111 | MP0005167_abnormal_blood-brain_barrier | 0.63279383 |
| 112 | MP0002332_abnormal_exercise_endurance | 0.61226119 |
| 113 | MP0000249_abnormal_blood_vessel | 0.60733188 |
| 114 | MP0008961_abnormal_basal_metabolism | 0.60461442 |
| 115 | MP0000230_abnormal_systemic_arterial | 0.60398890 |
| 116 | MP0002970_abnormal_white_adipose | 0.60027144 |
| 117 | MP0001756_abnormal_urination | 0.58873186 |
| 118 | MP0002249_abnormal_larynx_morphology | 0.58820546 |
| 119 | MP0002998_abnormal_bone_remodeling | 0.58145005 |
| 120 | MP0001661_extended_life_span | 0.57172638 |
| 121 | MP0009384_cardiac_valve_regurgitation | 0.56917029 |
| 122 | MP0009250_abnormal_appendicular_skeleto | 0.56297760 |
| 123 | MP0005501_abnormal_skin_physiology | 0.56191200 |
| 124 | MP0002254_reproductive_system_inflammat | 0.56139352 |
| 125 | MP0005448_abnormal_energy_balance | 0.53417520 |
| 126 | MP0005452_abnormal_adipose_tissue | 0.53349851 |
| 127 | MP0000858_altered_metastatic_potential | 0.53072945 |
| 128 | MP0005647_abnormal_sex_gland | 0.53046975 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased connective tissue (HP:0009025) | 6.57976603 |
| 2 | Type 1 muscle fiber predominance (HP:0003803) | 6.06916164 |
| 3 | Muscle fiber splitting (HP:0003555) | 5.90798684 |
| 4 | Ankle contracture (HP:0006466) | 5.52684389 |
| 5 | Protrusio acetabuli (HP:0003179) | 5.29175072 |
| 6 | Broad metatarsal (HP:0001783) | 5.01028831 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 4.68787990 |
| 8 | Premature rupture of membranes (HP:0001788) | 4.50708382 |
| 9 | Increased variability in muscle fiber diameter (HP:0003557) | 4.49533608 |
| 10 | Abnormality of complement system (HP:0005339) | 4.41080659 |
| 11 | Follicular hyperkeratosis (HP:0007502) | 4.36053079 |
| 12 | Vascular tortuosity (HP:0004948) | 4.11636854 |
| 13 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.09068937 |
| 14 | Spinal rigidity (HP:0003306) | 4.06554733 |
| 15 | Aortic dissection (HP:0002647) | 3.94513128 |
| 16 | Exercise-induced myalgia (HP:0003738) | 3.90553729 |
| 17 | Slender build (HP:0001533) | 3.80965065 |
| 18 | Hyporeflexia of lower limbs (HP:0002600) | 3.76883774 |
| 19 | Sudden death (HP:0001699) | 3.71671056 |
| 20 | Mildly elevated creatine phosphokinase (HP:0008180) | 3.66231576 |
| 21 | Right ventricular cardiomyopathy (HP:0011663) | 3.66089615 |
| 22 | Cerebral aneurysm (HP:0004944) | 3.65942511 |
| 23 | Difficulty running (HP:0009046) | 3.53769511 |
| 24 | Ventricular tachycardia (HP:0004756) | 3.52711764 |
| 25 | Joint stiffness (HP:0001387) | 3.49444045 |
| 26 | Exercise-induced muscle cramps (HP:0003710) | 3.49391904 |
| 27 | Round ear (HP:0100830) | 3.44066296 |
| 28 | Aortic aneurysm (HP:0004942) | 3.30396057 |
| 29 | Calf muscle hypertrophy (HP:0008981) | 3.27975364 |
| 30 | Soft skin (HP:0000977) | 3.21572462 |
| 31 | Lipoatrophy (HP:0100578) | 3.14995956 |
| 32 | Shallow orbits (HP:0000586) | 3.10903843 |
| 33 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.10322720 |
| 34 | Myoglobinuria (HP:0002913) | 2.99761118 |
| 35 | Atrophic scars (HP:0001075) | 2.98974074 |
| 36 | Abnormality of the calf musculature (HP:0001430) | 2.98687342 |
| 37 | Wrist flexion contracture (HP:0001239) | 2.97751625 |
| 38 | Bladder diverticulum (HP:0000015) | 2.91729637 |
| 39 | Myotonia (HP:0002486) | 2.91261317 |
| 40 | Mitral valve prolapse (HP:0001634) | 2.91016989 |
| 41 | Fragile skin (HP:0001030) | 2.86354023 |
| 42 | Aortic valve stenosis (HP:0001650) | 2.80266127 |
| 43 | Striae distensae (HP:0001065) | 2.78528705 |
| 44 | Hypertriglyceridemia (HP:0002155) | 2.78164417 |
| 45 | Dilatation of the ascending aorta (HP:0005111) | 2.76397440 |
| 46 | Arterial tortuosity (HP:0005116) | 2.74019956 |
| 47 | Emphysema (HP:0002097) | 2.72675595 |
| 48 | Pulmonary artery stenosis (HP:0004415) | 2.71585289 |
| 49 | Polycythemia (HP:0001901) | 2.69192707 |
| 50 | Genu recurvatum (HP:0002816) | 2.68158698 |
| 51 | Glomerulonephritis (HP:0000099) | 2.64912850 |
| 52 | Atrial fibrillation (HP:0005110) | 2.62170252 |
| 53 | Rectal prolapse (HP:0002035) | 2.59906333 |
| 54 | EMG: myopathic abnormalities (HP:0003458) | 2.52066151 |
| 55 | Biconcave vertebral bodies (HP:0004586) | 2.50927761 |
| 56 | Asymmetric septal hypertrophy (HP:0001670) | 2.50234452 |
| 57 | Muscle fiber inclusion bodies (HP:0100299) | 2.48016692 |
| 58 | Ectopia lentis (HP:0001083) | 2.42118229 |
| 59 | Primary atrial arrhythmia (HP:0001692) | 2.41692242 |
| 60 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.41392141 |
| 61 | Cervical subluxation (HP:0003308) | 2.39307928 |
| 62 | Acanthosis nigricans (HP:0000956) | 2.36309070 |
| 63 | Nephritis (HP:0000123) | 2.35488400 |
| 64 | Supraventricular arrhythmia (HP:0005115) | 2.34631414 |
| 65 | Mitral regurgitation (HP:0001653) | 2.31449575 |
| 66 | Supraventricular tachycardia (HP:0004755) | 2.29532796 |
| 67 | Flat cornea (HP:0007720) | 2.28957187 |
| 68 | Nuclear cataract (HP:0100018) | 2.28463823 |
| 69 | Subaortic stenosis (HP:0001682) | 2.28463738 |
| 70 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.28463738 |
| 71 | Difficulty climbing stairs (HP:0003551) | 2.28444669 |
| 72 | Generalized amyotrophy (HP:0003700) | 2.28425330 |
| 73 | Overgrowth (HP:0001548) | 2.26539278 |
| 74 | Limb-girdle muscle weakness (HP:0003325) | 2.24847446 |
| 75 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.22975168 |
| 76 | Venous abnormality (HP:0002624) | 2.22304007 |
| 77 | Hyperextensible skin (HP:0000974) | 2.20309028 |
| 78 | Aneurysm (HP:0002617) | 2.19960450 |
| 79 | Obstructive sleep apnea (HP:0002870) | 2.19672113 |
| 80 | Mitral stenosis (HP:0001718) | 2.19576623 |
| 81 | Muscle stiffness (HP:0003552) | 2.19408978 |
| 82 | Facial diplegia (HP:0001349) | 2.16212697 |
| 83 | Ovoid vertebral bodies (HP:0003300) | 2.14695190 |
| 84 | Neck muscle weakness (HP:0000467) | 2.13061230 |
| 85 | Amyloidosis (HP:0011034) | 2.12522383 |
| 86 | Venous insufficiency (HP:0005293) | 2.12106334 |
| 87 | Rhabdomyolysis (HP:0003201) | 2.11327989 |
| 88 | Neonatal short-limb short stature (HP:0008921) | 2.11079037 |
| 89 | Bowel diverticulosis (HP:0005222) | 2.10603381 |
| 90 | Distal lower limb muscle weakness (HP:0009053) | 2.10335710 |
| 91 | Dilated cardiomyopathy (HP:0001644) | 2.10110420 |
| 92 | Proximal amyotrophy (HP:0007126) | 2.09158460 |
| 93 | Beaking of vertebral bodies (HP:0004568) | 2.09067761 |
| 94 | Complement deficiency (HP:0004431) | 2.07062125 |
| 95 | Patent foramen ovale (HP:0001655) | 2.06502974 |
| 96 | Axonal loss (HP:0003447) | 2.05018187 |
| 97 | Bundle branch block (HP:0011710) | 2.03406715 |
| 98 | Broad ribs (HP:0000885) | 2.01757457 |
| 99 | Spontaneous hematomas (HP:0007420) | 2.01476614 |
| 100 | Mild short stature (HP:0003502) | 2.01235117 |
| 101 | Nemaline bodies (HP:0003798) | 2.00891956 |
| 102 | Limited hip movement (HP:0008800) | 2.00066320 |
| 103 | Bronchomalacia (HP:0002780) | 1.99934691 |
| 104 | Joint laxity (HP:0001388) | 1.98327685 |
| 105 | Wormian bones (HP:0002645) | 1.97993774 |
| 106 | Spinal cord compression (HP:0002176) | 1.97465542 |
| 107 | Scapular winging (HP:0003691) | 1.95946723 |
| 108 | Elbow flexion contracture (HP:0002987) | 1.95287751 |
| 109 | Hyperlipoproteinemia (HP:0010980) | 1.95069262 |
| 110 | Bone cyst (HP:0012062) | 1.94161824 |
| 111 | Peritonitis (HP:0002586) | 1.93588088 |
| 112 | Lymphangioma (HP:0100764) | 1.91338184 |
| 113 | Distal arthrogryposis (HP:0005684) | 1.91329507 |
| 114 | Palpitations (HP:0001962) | 1.90494359 |
| 115 | Hip contracture (HP:0003273) | 1.89518182 |
| 116 | Conjunctival hamartoma (HP:0100780) | 1.88759399 |
| 117 | Blue sclerae (HP:0000592) | 1.86513288 |
| 118 | Insulin resistance (HP:0000855) | 1.85391473 |
| 119 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.84658838 |
| 120 | Osteolytic defects of the hand bones (HP:0009699) | 1.84658838 |
| 121 | Ventricular arrhythmia (HP:0004308) | 1.82767351 |
| 122 | Prolonged QT interval (HP:0001657) | 1.82476688 |
| 123 | Growth hormone excess (HP:0000845) | 1.82432138 |
| 124 | Redundant skin (HP:0001582) | 1.82394659 |
| 125 | Spondylolisthesis (HP:0003302) | 1.81588194 |
| 126 | Abnormal delivery (HP:0001787) | 1.80135717 |
| 127 | Oligomenorrhea (HP:0000876) | 1.79083353 |
| 128 | Abnormal atrioventricular conduction (HP:0005150) | 1.76729873 |
| 129 | Achilles tendon contracture (HP:0001771) | 1.75685806 |
| 130 | Mesangial abnormality (HP:0001966) | 1.75248548 |
| 131 | Wide anterior fontanel (HP:0000260) | 1.74845342 |
| 132 | Coxa vara (HP:0002812) | 1.74254043 |
| 133 | Back pain (HP:0003418) | 1.74238244 |
| 134 | Testicular atrophy (HP:0000029) | 1.73727698 |
| 135 | Limb-girdle muscle atrophy (HP:0003797) | 1.72399531 |
| 136 | Ulnar deviation of the wrist (HP:0003049) | 1.72314297 |
| 137 | Infantile muscular hypotonia (HP:0008947) | 1.72239629 |
| 138 | Hypoplasia of the iris (HP:0007676) | 1.71987173 |
| 139 | Atrioventricular block (HP:0001678) | 1.71244173 |
| 140 | Abnormality of dentin (HP:0010299) | 1.70944972 |
| 141 | Osteoarthritis (HP:0002758) | 1.70474526 |
| 142 | Abnormality of the 4th metacarpal (HP:0010012) | 1.69430106 |
| 143 | Small epiphyses (HP:0010585) | 1.69131386 |
| 144 | Aortic regurgitation (HP:0001659) | 1.68378178 |
| 145 | Hypercortisolism (HP:0001578) | 1.68245023 |
| 146 | Vertebral compression fractures (HP:0002953) | 1.68200640 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 5.58179328 |
| 2 | TRIB3 | 4.60741146 |
| 3 | MYLK | 3.24208351 |
| 4 | RIPK1 | 2.71236969 |
| 5 | SIK1 | 2.59613279 |
| 6 | LMTK2 | 2.58068297 |
| 7 | PHKG1 | 2.50070672 |
| 8 | PHKG2 | 2.50070672 |
| 9 | TESK1 | 2.41990575 |
| 10 | TIE1 | 2.37065710 |
| 11 | DMPK | 2.36591981 |
| 12 | DDR2 | 2.36484787 |
| 13 | ERN1 | 2.31413383 |
| 14 | TGFBR2 | 2.29829906 |
| 15 | OBSCN | 2.27568726 |
| 16 | PDK4 | 2.23910667 |
| 17 | PDK3 | 2.23910667 |
| 18 | PDGFRA | 2.13615738 |
| 19 | PKN2 | 2.05187190 |
| 20 | CAMK1D | 2.00714772 |
| 21 | EPHB2 | 1.95348123 |
| 22 | BCKDK | 1.94541736 |
| 23 | EPHB1 | 1.64673164 |
| 24 | CAMK1G | 1.54675719 |
| 25 | MST1R | 1.48172506 |
| 26 | ABL2 | 1.46776577 |
| 27 | KIT | 1.46740598 |
| 28 | ARAF | 1.44515644 |
| 29 | MOS | 1.41544626 |
| 30 | PRPF4B | 1.38773037 |
| 31 | PIK3CA | 1.38731687 |
| 32 | PDK2 | 1.38492323 |
| 33 | GRK5 | 1.38264307 |
| 34 | MAPK7 | 1.25845352 |
| 35 | FER | 1.24550860 |
| 36 | ILK | 1.22782569 |
| 37 | MAPKAPK3 | 1.21055581 |
| 38 | MAP2K3 | 1.20598594 |
| 39 | MAP3K3 | 1.10214148 |
| 40 | PINK1 | 1.09079748 |
| 41 | MAP3K7 | 1.08520386 |
| 42 | FGFR4 | 1.08355538 |
| 43 | PTK6 | 1.07115036 |
| 44 | PIK3CG | 1.02844327 |
| 45 | EPHA3 | 1.01674292 |
| 46 | PRKD1 | 1.01229747 |
| 47 | LATS1 | 0.99798588 |
| 48 | PRKG2 | 0.99677156 |
| 49 | MARK2 | 0.94628890 |
| 50 | INSRR | 0.94130346 |
| 51 | TBK1 | 0.93363062 |
| 52 | LATS2 | 0.92849720 |
| 53 | MAPK4 | 0.92585904 |
| 54 | TYK2 | 0.91164485 |
| 55 | PAK2 | 0.89657263 |
| 56 | ADRBK1 | 0.88832611 |
| 57 | TRPM7 | 0.87615546 |
| 58 | PRKAA2 | 0.84965386 |
| 59 | ROCK1 | 0.81625702 |
| 60 | PTK2B | 0.79770322 |
| 61 | MET | 0.79411167 |
| 62 | MAP3K13 | 0.79382049 |
| 63 | DAPK3 | 0.78062193 |
| 64 | EEF2K | 0.76079142 |
| 65 | PRKCH | 0.75994602 |
| 66 | MAPK12 | 0.74932750 |
| 67 | PDGFRB | 0.74637547 |
| 68 | LRRK2 | 0.74035968 |
| 69 | BMX | 0.73997012 |
| 70 | LIMK1 | 0.73362287 |
| 71 | FGFR3 | 0.72126578 |
| 72 | CSK | 0.71695372 |
| 73 | PIM2 | 0.68130133 |
| 74 | PRKD3 | 0.67016998 |
| 75 | BLK | 0.65615416 |
| 76 | FGFR2 | 0.63025023 |
| 77 | JAK1 | 0.62721485 |
| 78 | ZAP70 | 0.62448650 |
| 79 | STK24 | 0.61876313 |
| 80 | MAP2K1 | 0.60051704 |
| 81 | FES | 0.59956306 |
| 82 | MAP3K11 | 0.59881308 |
| 83 | HIPK2 | 0.59390903 |
| 84 | NME1 | 0.59359286 |
| 85 | ROCK2 | 0.57934854 |
| 86 | RET | 0.55363380 |
| 87 | NTRK1 | 0.54440665 |
| 88 | PRKG1 | 0.54322188 |
| 89 | PAK3 | 0.54101503 |
| 90 | ICK | 0.52129862 |
| 91 | PRKAA1 | 0.51966706 |
| 92 | GSK3A | 0.51224831 |
| 93 | PRKD2 | 0.51008544 |
| 94 | NEK1 | 0.50732681 |
| 95 | MAP3K6 | 0.50156799 |
| 96 | RPS6KA2 | 0.48764752 |
| 97 | CDC42BPA | 0.47806664 |
| 98 | JAK3 | 0.46799609 |
| 99 | NLK | 0.46055906 |
| 100 | KSR2 | 0.45978480 |
| 101 | MTOR | 0.45891801 |
| 102 | RPS6KL1 | 0.45164694 |
| 103 | RPS6KC1 | 0.45164694 |
| 104 | CAMK2G | 0.44258429 |
| 105 | TAOK1 | 0.44246085 |
| 106 | MAPK15 | 0.44189795 |
| 107 | DAPK2 | 0.43941121 |
| 108 | NEK9 | 0.43806675 |
| 109 | MARK1 | 0.43600003 |
| 110 | STK38 | 0.42426060 |
| 111 | JAK2 | 0.42319224 |
| 112 | RPS6KA6 | 0.41477033 |
| 113 | PTK2 | 0.41004366 |
| 114 | MAP2K2 | 0.40985700 |
| 115 | FGFR1 | 0.40461352 |
| 116 | PAK6 | 0.40289049 |
| 117 | MAPK3 | 0.40027588 |
| 118 | PAK4 | 0.39579375 |
| 119 | STK38L | 0.38738569 |
| 120 | WNK1 | 0.37505001 |
| 121 | TGFBR1 | 0.36507956 |
| 122 | PAK1 | 0.36206492 |
| 123 | PDPK1 | 0.35434596 |
| 124 | KDR | 0.31812701 |
| 125 | MAP3K1 | 0.31806320 |
| 126 | CAMK1 | 0.30637915 |
| 127 | CAMK4 | 0.30182464 |
| 128 | CAMK2D | 0.29297557 |
| 129 | PKN1 | 0.27677517 |
| 130 | FLT3 | 0.27232702 |
| 131 | PRKACG | 0.27055399 |
| 132 | SRC | 0.26858800 |
| 133 | MAP3K2 | 0.26655341 |
| 134 | MAPKAPK2 | 0.25882413 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.57553608 |
| 2 | ECM-receptor interaction_Homo sapiens_hsa04512 | 3.39603169 |
| 3 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.64480725 |
| 4 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.59032710 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.58442409 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.52221933 |
| 7 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.46354437 |
| 8 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.38769300 |
| 9 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.32019936 |
| 10 | Focal adhesion_Homo sapiens_hsa04510 | 2.20196664 |
| 11 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.12675037 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.12496096 |
| 13 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.06689229 |
| 14 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.02740823 |
| 15 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.95376677 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.93184911 |
| 17 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.73743069 |
| 18 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.68672423 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.68496486 |
| 20 | Insulin resistance_Homo sapiens_hsa04931 | 1.61259379 |
| 21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.56587861 |
| 22 | Amoebiasis_Homo sapiens_hsa05146 | 1.49357893 |
| 23 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.44379059 |
| 24 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.38341993 |
| 25 | Viral myocarditis_Homo sapiens_hsa05416 | 1.31338920 |
| 26 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.30474250 |
| 27 | Carbon metabolism_Homo sapiens_hsa01200 | 1.30244097 |
| 28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.28000536 |
| 29 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.26198595 |
| 30 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.18525686 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.16023958 |
| 32 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.13383474 |
| 33 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.09501345 |
| 34 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.06387252 |
| 35 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.05100186 |
| 36 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.03905227 |
| 37 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.02823711 |
| 38 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.98948925 |
| 39 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.95748012 |
| 40 | Malaria_Homo sapiens_hsa05144 | 0.94351615 |
| 41 | Renin secretion_Homo sapiens_hsa04924 | 0.93741985 |
| 42 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.92206541 |
| 43 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.91786601 |
| 44 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.89890299 |
| 45 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.89347834 |
| 46 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.89285891 |
| 47 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.87127521 |
| 48 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.86999595 |
| 49 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.86898813 |
| 50 | Adherens junction_Homo sapiens_hsa04520 | 0.85394337 |
| 51 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.82681468 |
| 52 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.81030445 |
| 53 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.79290339 |
| 54 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.78666072 |
| 55 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.77160317 |
| 56 | Platelet activation_Homo sapiens_hsa04611 | 0.76357460 |
| 57 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.76275680 |
| 58 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.75310563 |
| 59 | Phagosome_Homo sapiens_hsa04145 | 0.73746422 |
| 60 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.73475961 |
| 61 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.72372392 |
| 62 | Bladder cancer_Homo sapiens_hsa05219 | 0.72111257 |
| 63 | Lysosome_Homo sapiens_hsa04142 | 0.72108061 |
| 64 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.69949128 |
| 65 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.69770135 |
| 66 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.68183479 |
| 67 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.68097947 |
| 68 | Tight junction_Homo sapiens_hsa04530 | 0.68085234 |
| 69 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.67665864 |
| 70 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.66064691 |
| 71 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.64787979 |
| 72 | Prion diseases_Homo sapiens_hsa05020 | 0.64751831 |
| 73 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.64504477 |
| 74 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.62707720 |
| 75 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.61291830 |
| 76 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.61198891 |
| 77 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.59884536 |
| 78 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.58832172 |
| 79 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56816767 |
| 80 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.56488836 |
| 81 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.56390550 |
| 82 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.56357378 |
| 83 | Alzheimers disease_Homo sapiens_hsa05010 | 0.55991925 |
| 84 | Gap junction_Homo sapiens_hsa04540 | 0.55890026 |
| 85 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.55701260 |
| 86 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.54724721 |
| 87 | Lysine degradation_Homo sapiens_hsa00310 | 0.54659649 |
| 88 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.54381861 |
| 89 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.54289777 |
| 90 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.53927423 |
| 91 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.53426263 |
| 92 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.52250155 |
| 93 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.51507739 |
| 94 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.51460555 |
| 95 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.51363901 |
| 96 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.49209325 |
| 97 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.49195859 |
| 98 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.49083383 |
| 99 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.48753555 |
| 100 | Pathways in cancer_Homo sapiens_hsa05200 | 0.48638213 |
| 101 | Parkinsons disease_Homo sapiens_hsa05012 | 0.48107836 |
| 102 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.48102507 |
| 103 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.48078498 |
| 104 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.46045845 |
| 105 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.43946341 |
| 106 | Retinol metabolism_Homo sapiens_hsa00830 | 0.43186084 |
| 107 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.42947331 |
| 108 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.42604488 |
| 109 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.41468525 |
| 110 | Endocytosis_Homo sapiens_hsa04144 | 0.41250806 |
| 111 | Bile secretion_Homo sapiens_hsa04976 | 0.41149351 |
| 112 | Melanogenesis_Homo sapiens_hsa04916 | 0.40468625 |
| 113 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.39738267 |
| 114 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.39648330 |
| 115 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.39108992 |
| 116 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.37370651 |
| 117 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.37200362 |
| 118 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.37109877 |
| 119 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.36150688 |
| 120 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.34583523 |
| 121 | Circadian rhythm_Homo sapiens_hsa04710 | 0.34355272 |
| 122 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.33522456 |
| 123 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.33331561 |
| 124 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.32440190 |
| 125 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32122606 |
| 126 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.31905835 |
| 127 | Axon guidance_Homo sapiens_hsa04360 | 0.31135783 |
| 128 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.31113628 |
| 129 | Melanoma_Homo sapiens_hsa05218 | 0.31068220 |
| 130 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.30940473 |
| 131 | Pertussis_Homo sapiens_hsa05133 | 0.29830214 |
| 132 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.29210322 |
| 133 | Cocaine addiction_Homo sapiens_hsa05030 | 0.27922923 |

